Liraglutide in Obesity and Diabetes: Identification of CNS Targets Using fMRI

NCT01562678 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Effects of Liraglutide Administration on Brain Activity
Weight Loss
Hunger

Interventions

DRUG: Liraglutide
DRUG: Placebo

Sponsor

Beth Israel Deaconess Medical Center